 Peptide receptor radionuclide therapy

Peptide receptor radionuclide therapy (PRRT) is a form of targeted cancer treatment that utilizes radioactive substances attached to peptides—short chains of amino acids that can bind to specific receptors on the surface of certain cancer cells. This therapy is primarily used to treat neuroendocrine tumors (NETs), which are tumors that arise from neuroendocrine cells and often express specific receptors such as somatostatin receptors.